Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Down 64.3% in January

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) saw a significant decline in short interest during the month of January. As of January 15th, there was short interest totaling 3,024 shares, a decline of 64.3% from the December 31st total of 8,463 shares. Based on an average trading volume of 118,888 shares, the days-to-cover ratio is currently 0.0 days. Based on an average trading volume of 118,888 shares, the days-to-cover ratio is currently 0.0 days.

Alpha Tau Medical Price Performance

Shares of DRTSW traded down $0.12 during midday trading on Thursday, reaching $0.93. The stock had a trading volume of 10,220 shares, compared to its average volume of 100,985. The company’s fifty day simple moving average is $0.50 and its two-hundred day simple moving average is $0.37. Alpha Tau Medical has a 1-year low of $0.13 and a 1-year high of $1.18.

About Alpha Tau Medical

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.